NYSE · Financial Statements

Stryker Corporation (SYK) Revenue, Earnings & Financial Statements

$317.54 NYSE: SYK Market Cap $120.88B

Data as of Nov 17, 2026 close · Statements through the quarter ended Jun 2026 · Source: Financial Modeling Prep (methodology)

Stryker Corporation most recently reported annual revenue of $25.1B, net profit of $3.2B. Revenue grew at an average annual rate of 11.8% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Stryker Corporation: Revenue rose from $11.3B in 2016 to $25.1B in 2025, a change of +121.8% over 9 years; net profit was positive in all 10 reported years; operating margin moved from 22.8% to 19.5%, a shift of -3.3 percentage points; the most recent year shows net profit of $3.2B.

Income Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Revenue$11.3B$12.4B$13.6B$14.9B$14.4B$17.1B$18.4B$20.5B$22.6B$25.1B
Operating Expenses$8.7B$9.7B$10.5B$11.5B$11.3B$13.3B$14.7B$16.2B$18.9B$20.2B
Operating Profit$2.6B$2.8B$3.1B$3.4B$3.0B$3.8B$3.7B$4.3B$3.7B$4.9B
Operating Margin22.8%22.2%22.8%22.8%21.1%22.0%20.2%20.9%16.3%19.5%
Other Income−$656.0M−$704.0M−$748.0M−$826.0M−$1.1B−$1.5B−$1.1B−$608.0M−$197.0M−$375.0M
Interest$228.0M$247.0M$264.0M$287.0M$315.0M$337.0M$337.0M$356.0M$396.0M$607.0M
Depreciation$546.0M$642.0M$723.0M$778.0M$812.0M$990.0M$998.0M$1.0B$1.1B$1.2B
Profit Before Tax$1.9B$2.1B$2.4B$2.6B$2.0B$2.3B$2.7B$3.7B$3.5B$4.5B
Tax rate (%)14.3%50.6%-50.8%18.7%18.2%12.6%12.1%13.8%14.3%28.1%
Net Profit$1.6B$1.0B$3.6B$2.1B$1.6B$2.0B$2.4B$3.2B$3.0B$3.2B
EPS$4.35$2.68$9.34$5.48$4.20$5.22$6.17$8.25$7.76$8.40

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricSep '23Dec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26
Revenue$4.9B$5.8B$5.2B$5.4B$5.5B$6.4B$5.9B$6.0B$6.1B$7.2B$6.0B$6.6B
Operating Expenses$3.9B$4.4B$4.2B$4.3B$4.3B$4.8B$4.7B$4.7B$4.9B$5.2B$5.1B$4.9B
Operating Profit$991.0M$1.4B$1.0B$1.2B$1.2B$1.7B$1.2B$1.4B$1.1B$2.0B$936.0M$1.7B
Operating Margin20.2%24.5%19.1%21.4%22.0%25.8%20.1%22.6%18.7%27.4%15.6%25.2%
Interest$0$0$0$0$0$0$0$159.0M$157.0M$381.0M$148.0M$0
Profit Before Tax$869.0M$1.2B$923.0M$998.0M$1.0B$528.0M$764.0M$1.0B$1.0B$1.7B$850.0M$1.6B
Tax rate (%)20.4%6.8%14.6%17.3%20.0%-3.4%14.4%13.0%16.5%50.2%12.3%18.4%
Net Profit$692.0M$1.1B$788.0M$825.0M$834.0M$546.0M$654.0M$884.0M$859.0M$849.0M$745.0M$1.3B
EPS$1.80$2.98$2.05$2.14$2.16$1.41$1.69$2.29$2.22$2.20$1.93$3.30

Over the 10 years reported for Stryker Corporation, borrowings increased from $6.9B in 2016 to $16.4B in 2025, cash stood at $4.0B in the latest year, shareholders' equity was $38.0M, current assets covered current liabilities 1.89 times.

Balance Sheet — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Total Assets$20.4B$22.2B$27.2B$30.2B$34.3B$34.6B$36.9B$39.9B$43.0B$47.8B
Current Assets$7.9B$8.0B$9.7B$11.4B$9.7B$10.0B$10.3B$12.5B$14.8B$14.8B
Cash$3.3B$2.5B$3.6B$4.3B$2.9B$2.9B$1.8B$3.0B$3.7B$4.0B
Inventory$2.0B$2.5B$3.0B$3.3B$3.5B$3.3B$4.0B$4.8B$4.8B$5.3B
Receivables$2.0B$2.2B$2.3B$2.9B$2.7B$3.0B$3.6B$3.8B$4.0B$4.0B
Fixed Assets$1.6B$2.0B$2.3B$3.0B$3.2B$3.3B$3.4B$3.7B$4.0B$4.4B
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$68.0M$251.0M$83.0M$88.0M$85.0M$141.0M$174.0M$84.0M$880.0M$91.0M
Other Assets$6.4B$7.2B$8.6B$9.1B$12.8B$12.9B$14.9B$15.2B$15.9B$19.3B
Total Liabilities$10.9B$12.2B$15.5B$17.4B$21.2B$19.8B$20.3B$21.3B$22.3B$25.4B
Current Liabilities$2.6B$3.3B$4.8B$4.4B$5.0B$4.5B$6.3B$7.9B$7.6B$7.8B
Borrowings$6.9B$7.2B$9.9B$11.5B$14.4B$12.9B$13.5B$13.5B$14.1B$16.4B
Other Liabilities$4.0B$5.0B$5.6B$5.9B$6.8B$6.9B$6.7B$7.8B$8.2B$9.1B
Equity$37.0M$37.0M$37.0M$37.0M$38.0M$38.0M$38.0M$38.0M$38.0M$38.0M
Reserves$9.6B$10.0B$11.7B$12.8B$13.1B$14.9B$16.6B$18.6B$20.6B$22.4B

For Stryker Corporation, operating cash flow was positive in 10 of 10 reported years; free cash flow in the latest year was $4.3B; free cash flow was positive in 10 of 10 years; financing activities used $182.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Operating Cash Flow$1.9B$1.6B$2.6B$2.2B$3.3B$3.3B$2.6B$3.7B$4.2B$5.0B
Investing Cash Flow−$4.7B−$2.2B−$3.4B−$2.1B−$5.2B−$1.4B−$3.5B−$1.5B−$3.8B−$5.6B
Financing Cash Flow−$86.0M−$457.0M−$424.0M−$512.0M−$137.0M−$262.0M−$170.0M−$178.0M−$246.0M−$182.0M
Net Cash Flow−$63.0M−$774.0M$1.1B$721.0M−$1.4B$1.0M−$1.1B$1.1B$681.0M$359.0M
Free Cash Flow$1.4B$961.0M$2.0B$1.5B$2.8B$2.7B$2.0B$3.1B$3.5B$4.3B

Valuation & Return Ratios

MetricValue
PEG Ratio1.16
EV / EBITDA19.33
FCF Yield3.99%
Quick Ratio1.33
Interest Coverage6.88
Return 1Y-16.16%
Return 3Y12.69%
Return 5Y26.68%

Stryker Corporation (SYK) financials — frequently asked questions

What is Stryker Corporation's annual revenue?

Stryker Corporation (SYK) reported annual revenue of $25.1B in its most recent fiscal year.

What is Stryker Corporation's net profit?

Stryker Corporation (SYK) reported net profit of $3.2B in its most recent fiscal year.

What is SYK EV/EBITDA?

Stryker Corporation's enterprise value to EBITDA (EV/EBITDA) ratio is 19.33.

Revenue and earnings of other Medical - Devices stocks

ABT revenue $44.3BISRG revenue $10.1BMDT revenue $36.4BBSX revenue $20.1BEW revenue $6.1BRMD revenue $5.7BDXCM revenue $4.7BPHG revenue $17.8BZBH revenue $8.2BGKOS revenue $507.0MAll Medical - Devices stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
SYK Overview SYK Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.